vs
Side-by-side financial comparison of OFG BANCORP (OFG) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $184.3M, roughly 1.1× OFG BANCORP). OFG BANCORP runs the higher net margin — 30.3% vs 1.1%, a 29.2% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs 0.9%). OFG BANCORP produced more free cash flow last quarter ($199.3M vs $-26.8M). Over the past eight quarters, OFG BANCORP's revenue compounded faster (2.8% CAGR vs 0.8%).
OFG Bancorp, founded in 1964, is the financial holding company for Oriental Bank, located in San Juan, Puerto Rico. OFG offers a wide range of retail and commercial banking, lending and wealth management products, services and technology, primarily in Puerto Rico and the U.S. Virgin Islands through its principal subsidiaries: Oriental Bank, Oriental Financial Services LLC, and Oriental Insurance LLC. Its headquarters are located at Oriental Center, 254 Muñoz Rivera Avenue, San Juan, PR 00918....
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
OFG vs VREX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $184.3M | $209.6M |
| Net Profit | $55.9M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | 25.7% | 7.3% |
| Net Margin | 30.3% | 1.1% |
| Revenue YoY | 0.9% | 4.9% |
| Net Profit YoY | 11.0% | 866.7% |
| EPS (diluted) | $1.27 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $209.6M | ||
| Q4 25 | $184.3M | $228.9M | ||
| Q3 25 | $186.2M | $203.0M | ||
| Q2 25 | $182.4M | $212.9M | ||
| Q1 25 | $178.6M | $199.8M | ||
| Q4 24 | $182.7M | — | ||
| Q3 24 | $174.7M | $205.7M | ||
| Q2 24 | $179.8M | $209.1M |
| Q1 26 | — | $2.3M | ||
| Q4 25 | $55.9M | $12.2M | ||
| Q3 25 | $51.8M | $-89.1M | ||
| Q2 25 | $51.8M | $6.9M | ||
| Q1 25 | $45.6M | $-300.0K | ||
| Q4 24 | $50.3M | — | ||
| Q3 24 | $47.0M | $-51.1M | ||
| Q2 24 | $51.1M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 25.7% | 8.6% | ||
| Q3 25 | 33.0% | -39.8% | ||
| Q2 25 | 36.1% | 10.4% | ||
| Q1 25 | 33.3% | 5.6% | ||
| Q4 24 | 28.9% | — | ||
| Q3 24 | 35.4% | 5.3% | ||
| Q2 24 | 39.6% | 4.4% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | 30.3% | 5.3% | ||
| Q3 25 | 27.8% | -43.9% | ||
| Q2 25 | 28.4% | 3.2% | ||
| Q1 25 | 25.5% | -0.2% | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 26.9% | -24.8% | ||
| Q2 24 | 28.4% | 0.7% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $1.27 | $0.29 | ||
| Q3 25 | $1.16 | $-2.15 | ||
| Q2 25 | $1.15 | $0.17 | ||
| Q1 25 | $1.00 | $-0.01 | ||
| Q4 24 | $1.10 | — | ||
| Q3 24 | $1.00 | $-1.25 | ||
| Q2 24 | $1.08 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $1.4B | $476.9M |
| Total Assets | $12.5B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | $1.0B | $155.1M | ||
| Q3 25 | $740.3M | $152.6M | ||
| Q2 25 | $851.8M | $223.0M | ||
| Q1 25 | $710.6M | $212.6M | ||
| Q4 24 | $591.1M | — | ||
| Q3 24 | $680.6M | $200.5M | ||
| Q2 24 | $740.4M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | — | $476.9M | ||
| Q4 25 | $1.4B | $472.6M | ||
| Q3 25 | $1.4B | $455.3M | ||
| Q2 25 | $1.3B | $549.7M | ||
| Q1 25 | $1.3B | $540.2M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $529.1M | ||
| Q2 24 | $1.2B | $581.2M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $12.5B | $1.1B | ||
| Q3 25 | $12.2B | $1.1B | ||
| Q2 25 | $12.2B | $1.4B | ||
| Q1 25 | $11.7B | $1.3B | ||
| Q4 24 | $11.5B | — | ||
| Q3 24 | $11.5B | $1.2B | ||
| Q2 24 | $11.3B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.7M | $-16.1M |
| Free Cash FlowOCF − Capex | $199.3M | $-26.8M |
| FCF MarginFCF / Revenue | 108.1% | -12.8% |
| Capex IntensityCapex / Revenue | 10.0% | 5.1% |
| Cash ConversionOCF / Net Profit | 3.90× | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | $345.4M | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $217.7M | $7.9M | ||
| Q3 25 | $39.5M | $7.7M | ||
| Q2 25 | $35.9M | $16.6M | ||
| Q1 25 | $83.1M | $9.5M | ||
| Q4 24 | $252.5M | — | ||
| Q3 24 | $58.1M | $25.9M | ||
| Q2 24 | $95.1M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $199.3M | $2.3M | ||
| Q3 25 | $35.5M | $1.4M | ||
| Q2 25 | $31.8M | $9.8M | ||
| Q1 25 | $78.7M | $5.3M | ||
| Q4 24 | $231.2M | — | ||
| Q3 24 | $51.8M | $19.9M | ||
| Q2 24 | $90.4M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | 108.1% | 1.0% | ||
| Q3 25 | 19.1% | 0.7% | ||
| Q2 25 | 17.4% | 4.6% | ||
| Q1 25 | 44.1% | 2.7% | ||
| Q4 24 | 126.5% | — | ||
| Q3 24 | 29.6% | 9.7% | ||
| Q2 24 | 50.3% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 10.0% | 2.4% | ||
| Q3 25 | 2.1% | 3.1% | ||
| Q2 25 | 2.3% | 3.2% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 3.6% | 2.9% | ||
| Q2 24 | 2.6% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | 3.90× | 0.65× | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 0.69× | 2.41× | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 5.02× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.86× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OFG
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
